BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19101511)

  • 1. Bim is reversibly phosphorylated but plays a limited role in paclitaxel cytotoxicity of breast cancer cell lines.
    Czernick M; Rieger A; Goping IS
    Biochem Biophys Res Commun; 2009 Jan; 379(1):145-50. PubMed ID: 19101511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells.
    Kutuk O; Letai A
    Cell Death Differ; 2010 Oct; 17(10):1624-35. PubMed ID: 20431602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim.
    Li R; Moudgil T; Ross HJ; Hu HM
    Cell Death Differ; 2005 Mar; 12(3):292-303. PubMed ID: 15711598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Bim in apoptosis induced in H460 lung tumor cells by the spindle poison Combretastatin-A4.
    Mendez G; Policarpi C; Cenciarelli C; Tanzarella C; Antoccia A
    Apoptosis; 2011 Sep; 16(9):940-9. PubMed ID: 21671007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin B1 interacts with the BH3-only protein Bim and mediates its phosphorylation by Cdk1 during mitosis.
    Mac Fhearraigh S; Mc Gee MM
    Cell Cycle; 2011 Nov; 10(22):3886-96. PubMed ID: 22071694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells.
    Ajabnoor GM; Crook T; Coley HM
    Cell Death Dis; 2012 Jan; 3(1):e260. PubMed ID: 22278287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL.
    Gilley R; Lochhead PA; Balmanno K; Oxley D; Clark J; Cook SJ
    Cell Signal; 2012 Jan; 24(1):170-80. PubMed ID: 21924351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines.
    Sunters A; Fernández de Mattos S; Stahl M; Brosens JJ; Zoumpoulidou G; Saunders CA; Coffer PJ; Medema RH; Coombes RC; Lam EW
    J Biol Chem; 2003 Dec; 278(50):49795-805. PubMed ID: 14527951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprenoid-independent pathway is involved in apoptosis induced by risedronate, a bisphosphonate, in which Bim plays a critical role in breast cancer cell line MCF-7.
    Suyama K; Noguchi Y; Tanaka T; Yoshida T; Shibata T; Saito Y; Tatsuno I
    Oncol Rep; 2007 Nov; 18(5):1291-8. PubMed ID: 17914587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
    Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
    Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy.
    Tan TT; Degenhardt K; Nelson DA; Beaudoin B; Nieves-Neira W; Bouillet P; Villunger A; Adams JM; White E
    Cancer Cell; 2005 Mar; 7(3):227-38. PubMed ID: 15766661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Bim by brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from paclitaxel but not etoposide or cisplatin-induced cell death.
    Li Z; Zhang J; Liu Z; Woo CW; Thiele CJ
    Cell Death Differ; 2007 Feb; 14(2):318-26. PubMed ID: 16778834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.
    Savry A; Carre M; Berges R; Rovini A; Pobel I; Chacon C; Braguer D; Bourgarel-Rey V
    Neoplasia; 2013 Jan; 15(1):49-60. PubMed ID: 23358890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An essential role for p73 in regulating mitotic cell death.
    Toh WH; Nam SY; Sabapathy K
    Cell Death Differ; 2010 May; 17(5):787-800. PubMed ID: 20010785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells.
    Zhu BK; Wang P; Zhang XD; Jiang CC; Chen LH; Avery-Kiejda KA; Watts R; Hersey P
    Anticancer Drugs; 2008 Feb; 19(2):189-200. PubMed ID: 18176116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of SIAH1 is downregulated and associated with Bim and apoptosis in human breast cancer tissues and cells.
    Wen YY; Yang ZQ; Song M; Li BL; Yao XH; Chen XL; Zhao J; Lu YY; Zhu JJ; Wang EH
    Mol Carcinog; 2010 May; 49(5):440-9. PubMed ID: 20082325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X; Tsang YH; Yu Q
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
    Giannakakou P; Robey R; Fojo T; Blagosklonny MV
    Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the JNK pathway promotes phosphorylation and degradation of BimEL--a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia.
    Leung KT; Li KK; Sun SS; Chan PK; Ooi VE; Chiu LC
    Carcinogenesis; 2008 Mar; 29(3):544-51. PubMed ID: 18174237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.